Pharmacokinetics of oral terbinafine in horses and Greyhound dogs
Authors:
- 14 April 2011
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 34 (3) , 232-237
Abstract
Williams, M.M., Davis, E.G., KuKanich, B. Pharmacokinetics of oral terbinafine in horses and Greyhound dogs. J. vet. Pharmacol. Therap.34, 232–237. The objective of the study was to assess the pharmacokinetics of terbinafine administered orally to horses and Greyhound dogs. A secondary objective was to assess terbinafine metabolites. Six healthy horses and six healthy Greyhound dogs were included in the pharmacokinetic data. The targeted dose of terbinafine was 20 and 30 mg/kg for horses and dogs, respectively. Blood was collected at predetermined intervals for the quantification of terbinafine concentrations with liquid chromatography and mass spectrometry. The half-life (geometric mean) was 8.1 and 8.6 h for horses and Greyhounds, respectively. The mean maximum plasma concentration was 0.31 and 4.01 μg/mL for horses and Greyhounds, respectively. The area under the curve (to infinity) was 1.793 h·μg/mL for horses and 17.253 h·μg/mL for Greyhounds. Adverse effects observed in one study horse included pawing at the ground, curling lips, head shaking, anxiety and circling, but these resolved spontaneously within 30 min of onset. No adverse effects were noted in the dogs. Ions consistent with carboxyterbinafine, n-desmethylterbinafine, hydroxyterbinafine and desmethylhydroxyterbinafine were identified in horse and Greyhound plasma after terbinafine administration. Further studies are needed assessing the safety and efficacy of terbinafine in horses and dogs.Keywords
This publication has 29 references indexed in Scilit:
- The pharmacokinetics of ketoconazole and its effects on the pharmacokinetics of midazolam and fentanyl in dogsJournal of Veterinary Pharmacology and Therapeutics, 2010
- Effects of ketoconazole on the pharmacokinetics and pharmacodynamics of morphine in healthy GreyhoundsAmerican Journal of Veterinary Research, 2008
- Comparative disposition of pharmacologic markers for cytochrome P‐450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogsJournal of Veterinary Pharmacology and Therapeutics, 2007
- Pharmacokinetics of voriconazole after oral and intravenous administration to horsesAmerican Journal of Veterinary Research, 2006
- Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment ofMalasseziadermatitis in dogs – a pilot studyVeterinary Dermatology, 2005
- Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differencesXenobiotica, 2000
- Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolitesAntimicrobial Agents and Chemotherapy, 1995
- Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjectsBiopharmaceutics & Drug Disposition, 1995
- Body fluid and endometrial concentrations of ketoconazole in mares after intravenous injection or repeated gavageEquine Veterinary Journal, 1989
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985